What is the NOAEL for Aspartame?
Aspartame has 100 NOAEL studies in the database. The lowest reported value is 0.5 mg/kg bw/day. Source: WHO/JECFA.
Also known as: 3-Amino-N-(alpha-carboxyphenethyl)succinamic acid N-methyl ester, stereoisomer, 3-Amino-N-(alpha-methoxycarbonylphenethyl) succinamic acid, Aspartame, L,L-alpha-, N-L-alpha-Aspartyl-L-phenylalanine 1-methyl ester, EINECS 245-261-3 (+14 more)
CAS 22839-47-0
Aspartame (CAS 22839-47-0) is a chemical substance; key hazard signal: IARC Group 2B. Key regulatory status: 4 regulatory/inventory lists, cosmetic ingredient cross-reference; source data from EPA ToxValDB, EPA CPDat, AICIS, IARC.
CAS, identifiers, formula, and alternate names for the matched substance record.
Carcinogenic hazard classification from IARC monograph evaluations.
| Group | Meaning | Evaluated | Volume |
|---|---|---|---|
| Group 2B | Possibly carcinogenic | 2023 | 134 |
Industrial and product-use categories associated with this substance.
Inventory, screening, and regulatory list matches from public chemical databases.
| List | Keyword | Source |
|---|---|---|
| pharmaceutical | US International Trade Commission | CPCat |
| food_additive; Substances Added to Food (formerly EAFUS) (2/2019) | FDA | United States Food and Drug Administration (FDA) |
| Canada; pharmaceutical | DrugBank | DrugBank |
| Canada; pharmaceutical | DrugBank | DrugBank |
Toxicology endpoints rendered from public NOAEL study rows.
| Value | Unit | Endpoint | Route | Species | Source |
|---|---|---|---|---|---|
| 53.8124788963568 | uM | AC50 | - | - | NTP ICE endocrine |
| 38.6854899573427 | uM | ACC | - | - | NTP ICE endocrine |
| range:0-0.50.5 | mg/kg bw/day | ADI | - | - | WHO/JECFA |
| range:0-0.50.5 | mg/kg bw/day | ADI | - | - | WHO/JECFA |
| range:0-0.50.5 | mg/kg bw/day | ADI | - | - | WHO/JECFA |
| range:0-0.50.5 | mg/kg bw/day | ADI | - | - | WHO/JECFA |
| range:0-2.52.5 | mg/kg bw/day | ADI | - | - | WHO/JECFA |
| range:0-2.52.5 | mg/kg bw/day | ADI | - | - | WHO/JECFA |
| range:0-2.52.5 | mg/kg bw/day | ADI | - | - | WHO/JECFA |
| range:0-2.52.5 | mg/kg bw/day | ADI | - | - | WHO/JECFA |
| range:0-33 | mg/kg bw/day | ADI | - | - | WHO/JECFA |
| range:0-33 | mg/kg bw/day | ADI | - | - | WHO/JECFA |
| range:0-33 | mg/kg bw/day | ADI | - | - | WHO/JECFA |
| range:0-33 | mg/kg bw/day | ADI | - | - | WHO/JECFA |
| range:0-55 | mg/kg bw/day | ADI | oral | - | WHO/JECFA |
| range:0-55 | mg/kg bw/day | ADI | - | - | WHO/JECFA |
| range:0-55 | mg/kg bw/day | ADI | oral | - | WHO/JECFA |
| range:0-55 | mg/kg bw/day | ADI | - | - | WHO/JECFA |
| range:0-7.57.5 | mg/kg bw/day | ADI | - | - | WHO/JECFA |
| range:0-7.57.5 | mg/kg bw/day | ADI | - | - | WHO/JECFA |
| =7.5 | mg/kg bw/day | ADI | - | - | WHO/JECFA |
| =7.5 | mg/kg bw/day | ADI | - | - | WHO/JECFA |
| range:0-7.57.5 | mg/kg bw/day | ADI | - | - | WHO/JECFA |
| range:0-7.57.5 | mg/kg bw/day | ADI | - | - | WHO/JECFA |
| range:0-1010 | mg/kg bw/day | ADI | - | - | WHO/JECFA |
| range:0-1010 | mg/kg bw/day | ADI | - | - | WHO/JECFA |
| range:0-1010 | mg/kg bw/day | ADI | - | - | WHO/JECFA |
| range:0-1010 | mg/kg bw/day | ADI | - | - | WHO/JECFA |
| <=40 | mg/kg | ADI | oral | Human | WHO/JECFA |
| range:0-4040 | mg/kg bw/day | ADI | - | - | WHO/JECFA |
| range:0-4040 | mg/kg bw/day | ADI | - | - | WHO/JECFA |
| =40 | mg/kg bw/day | ADI | - | Consumers | EFSA |
| =40 | mg/kg bw/day | ADI | - | Bird | WHO/JECFA |
| =40 | mg/kg bw/day | ADI | - | Consumers | EFSA |
| =40 | mg/kg bw/day | ADI | - | Bird | WHO/JECFA |
| range:0-4040 | mg/kg bw/day | ADI | - | - | WHO/JECFA |
| range:0-4040 | mg/kg bw/day | ADI | - | - | WHO/JECFA |
| =50 | mg/kg bw/day | ADI | - | - | WHO/JECFA |
| =50 | mg/kg bw/day | ADI | - | - | WHO/JECFA |
| =250 | mg/kg bw/day | ADI | - | Rat | WHO/JECFA |
| =250 | mg/kg bw/day | ADI | - | Rat | WHO/JECFA |
| Z0H242BBR1 | UNII | FDA UNII substance identifier | - | - | openFDA substances |
| Z0H242BBR1 | UNII | FDA UNII substance identifier | - | - | openFDA substances |
| Z0H242BBR1 | UNII | FDA UNII substance identifier | - | - | openFDA substances |
| Z0H242BBR1 | UNII | FDA UNII substance identifier | - | - | openFDA substances |
| 2B | IARC group | IARC carcinogenicity classification | - | - | IARC Monographs |
| 2B | IARC group | IARC carcinogenicity classification | - | - | IARC Monographs |
| 2B | IARC group | IARC carcinogenicity classification | - | - | IARC Monographs |
| >10000 | mg/kg bw | LD50 | oral | Rat | NTP ICE acute oral |
| >10000 | mg/kg bw | LD50 | oral | Rat | NTP ICE acute oral |
Showing 50 of 100 studies
Australian industrial chemicals inventory status and applicable conditions.
Same-CAS cosmetic ingredient record for cross-vertical context.
Same-CAS pharmaceutical records from drug and bioactivity sources.
Same-CAS food additive, ADI, and GRAS records where available.
ADI: 40 mg/kg bw
View full food safety profile →Same-CAS cannabis compliance and lab records where available.
1 cannabis record found in efsa substances.
View full cannabis profile →Aspartame has 100 NOAEL studies in the database. The lowest reported value is 0.5 mg/kg bw/day. Source: WHO/JECFA.
Aspartame appears on 3 regulatory/inventory lists including pharmaceutical, food_additive; Substances Added to Food (formerly EAFUS) (2/2019), Canada; pharmaceutical. Source: EPA CPDat.
Aspartame is classified by IARC as Group 2B — possibly carcinogenic to humans (evaluated 2023). Source: IARC Monographs on the Identification of Carcinogenic Hazards to Humans.
Yes, Aspartame is also indexed as a cosmetic ingredient under the name Aspartame. View the full cosmetic safety profile on the ingredient page for detailed safety data, SCCS opinions, and regulatory status.
Safety data is sourced from EPA ToxValDB, EPA CPDat, AICIS (Australian Industrial Chemicals Introduction Scheme), EPA DSSTox, IARC Monographs, CosIng / Ingredients DB, ChEMBL / DailyMed, EFSA / FDA GRAS, cannabis regulatory/lab databases. All data traces to primary regulatory sources and is updated from official government databases.
Aspartame also appears in cosmetics, pharmaceutical, food safety, cannabis databases.